Furthermore, analysis of brain tissues from carriers of the TREM2 R47H variant, sporadic AD patients, and normal controls demonstrated that the TREM2 R47H variant is strongly associated with an increased risk of AD and can exacerbate neuroinflammation in the brains of AD patients. Here, TREM2 is linked to Alzheimer disease.